Accounting policy
Non-controlling interests in subsidiaries are measured at the proportionate share of the subsidiaries’ identifiable net assets. Profit-sharing arrangements are accounted for separately in equity by attributing any additional profits or losses to the controlling interest or non-controlling interest based on the terms of the agreement.
|
|
2025 |
|
2024 |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
Andre Pectin |
|
Yimante |
|
Other |
|
Total |
|
|
% of non-controlling interest |
|
25%/9.5% |
|
25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at January 1 |
|
54 |
|
100 |
|
32 |
|
186 |
|
162 |
|
|
|
|
|
|
|
|
|
|
|
Changes: |
|
|
|
|
|
|
|
– |
|
|
- Share of profit (loss) |
|
1 |
|
40 |
|
1 |
|
42 |
|
30 |
- Dividend paid |
|
(19) |
|
(36) |
|
(4) |
|
(59) |
|
(7) |
- Acquisitions |
|
(101) |
|
– |
|
– |
|
(101) |
|
– |
- Divestments |
|
– |
|
– |
|
– |
|
– |
|
(17) |
- Other consolidation changes |
|
79 |
|
– |
|
– |
|
79 |
|
(6) |
- Transfers |
|
– |
|
40 |
|
– |
|
40 |
|
19 |
- Exchange differences |
|
(1) |
|
(4) |
|
(3) |
|
(8) |
|
5 |
Total changes |
|
(41) |
|
40 |
|
(6) |
|
(7) |
|
24 |
|
|
|
|
|
|
|
|
|
|
|
Balance at December 31 |
|
13 |
|
140 |
|
26 |
|
179 |
|
186 |
The shareholding owned by dsm-firmenich in Yimante Health Ingredients (Jingzhou, China) Company Ltd. is 75%. Profits are distributed on a 50:50 basis. The impact of this arrangement has led to a transfer of €40 million (2024: €19 million) within equity from shareholders’ equity to non-controlling interest.
Following the classification of the ANH business as held-for-sale, the non-controlling interest in Yimante was reclassified accordingly at year-end 2025.
In the reporting period, dsm-firmenich acquired an additional 15.5% of the shares in Andre Pectin (Yantai, China) for a purchase price of €101 million. It also concluded with the minority shareholder on a reciprocal option to acquire the remaining 9.5% of the shares in Andre Pectin. See also Note 3 Change in the scope of consolidation and Note 20 Other non-current liabilities.
|
|
2025 |
|
2024 |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
Andre Pectin |
|
Yimante |
|
Other |
|
Total |
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
Goodwill and intangible assets |
|
30 |
|
17 |
|
– |
|
47 |
|
57 |
Property, plant and equipment |
|
37 |
|
100 |
|
31 |
|
168 |
|
190 |
Other non-current assets |
|
2 |
|
32 |
|
24 |
|
58 |
|
67 |
Inventories |
|
42 |
|
10 |
|
67 |
|
119 |
|
125 |
Receivables |
|
21 |
|
45 |
|
85 |
|
151 |
|
215 |
Current investments |
|
– |
|
– |
|
– |
|
– |
|
7 |
Cash and cash equivalents |
|
32 |
|
144 |
|
27 |
|
203 |
|
145 |
Total assets |
|
164 |
|
348 |
|
234 |
|
746 |
|
806 |
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
Provisions (non-current) |
|
8 |
|
– |
|
3 |
|
11 |
|
13 |
Borrowings (non-current) |
|
1 |
|
– |
|
7 |
|
8 |
|
29 |
Other non-current liabilities |
|
– |
|
1 |
|
5 |
|
6 |
|
7 |
Borrowings and derivatives (current) |
|
1 |
|
– |
|
– |
|
1 |
|
19 |
Other current liabilities |
|
19 |
|
33 |
|
83 |
|
135 |
|
104 |
Total liabilities |
|
29 |
|
34 |
|
98 |
|
161 |
|
172 |
|
|
|
|
|
|
|
|
|
|
|
Net assets (100% basis) |
|
135 |
|
314 |
|
136 |
|
585 |
|
634 |
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
91 |
|
365 |
|
325 |
|
781 |
|
706 |
Net profit for the year |
|
8 |
|
159 |
|
14 |
|
181 |
|
123 |
Cash provided by/(used in) operating activities |
|
47 |
|
293 |
|
45 |
|
385 |
|
153 |